**7. References**


the Lab Animal Resources technicians for animal care. We thank Christopher Oberley for reading the manuscript and Matt Gigot, Kim Luetkehoelter, Tonia Jorgenson, Manching Leung, Heather Sturm, Katie Halser, Carl Koschmann, Henri Kurniawan, Jessica Linzmeyer, Myrra Windau, Fatima Ashraf, Bridget Borg, and Eric Simpson for their contributions. This work was supported by grants from the U.S. National Institutes of Health (CA22484,

Bilger, A., Bennett, L.M., Carabeo, R.A., Chiaverotti, T.A., Dvorak, C., Liss, K.M.,

Birnbaum, D.J., Adelaide, J., Mamessier, E., Finetti, P., Lagarde, A., Monges, G., Viret, F.,

Blake, J.A., Bult, C.J., Kadin, J.A., Richardson, J.E., Eppig, J.T., & the Mouse Genome

Buendia, M.A. (2002). Genetic Alterations in Hepatoblastoma and Hepatocellular

Bugni, J.M., Poole, T.M., & Drinkwater, N.R. (2001). The little mutation suppresses DEN-

modulation of susceptibility. *Carcinogenesis,* Vol. 22, No. 11, pp. (1853-1862) Bürckstümmer, T., Baumann, C., Blüml, S., Dixit, E., Dürnberger, G., Jahn, H., Planyavsky,

Chochi, Y., Kawauchi, S., Nakao, M., Furuya, T., Hashimoto, K., Oga, A., Oka, M., & Sasaki,

Choubey, D., Duan, X., Dickerson, E., Ponomareva, L., Panchanathan, R., Shen, H., & Ratika

Climent, J., Martinez-Climent, J. A., Blesa, D., Garcia-Barchino M. J., & Saez R. *et al.* (2002).

Dragani, T. A. (2010). Risk of HCC: Genetic heterogeneity and complex genetics. *Journal of* 

Drinkwater, N.R., & Ginsler, J.J. (1986). Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. *Carcinogenesis,* Vol. 7, No. 10, pp. (1701-1707)

inflammasome. *Nature Immunology,* Vol. 10, pp. (266 - 272)

breast cancer. *Clin. Cancer Res.,* Vol. 8, pp. (3863–3869)

study. *J Pathol,* Vol. 217, No. 5, pp. (677-684)

*Res.,* Vol. 30, No. 6, pp. (371–380)

*Hepatology,* Vol. 52, pp. (252–257)

congenic lines. *Genetics,* Vol. 167, No. 2, pp. (859–866)

*Chromosomes & Cancer,* Vol. 50, pp. (456–465)

Schadewald, S.A., Pitot, H.C. & Drinkwater, N.R. (2004). A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of

Goncalves, A., Turrini, O., Delpero, J.-P., Iovanna, J., Giovannini, M., Birnbaum, D., & Chaffanet, M. (2011). Genome Profiling of Pancreatic Adenocarcinoma. *Genes,* 

Database Group. (2011). The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. *Nucleic Acids Res,* Vol.

Carcinoma: Common and Distinctive Aspects. *Med Pediatr Oncol,* 2002,Vol. 39, pp.

induced hepatocarcinogenesis in mice and abrogates genetic and hormonal

M., Bilban, M., Colinge, J., Bennett, K.L., & Superti-Furga, G. (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the

K. (2009). A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization

Srivastava. (2010). Interferon-Inducible p200-Family Proteins as Novel Sensors of Cytoplasmic DNA: Role in Inflammation and Autoimmunity. *J Interferon Cytokine* 

Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk

CA96654, CA07175, CA09135, and CA14520).

39, Suppl. 1, pp. (D842-D848)

(530–535)

**7. References** 

